Courtney T. Thorne's practice focuses on the representation of public companies and investment banks in the life sciences industry, with an emphasis on capital raising, public company counseling, foreign private issuer matters and securities law compliance. In addition to a robust US practice, she has substantial expertise advising non-US companies (known as foreign private issuers or FPIs) seeking to access the US capital markets and become a US public company. Over the past five years, Courtney has advised 30+ IPOs and offerings, with an aggregate value of approximately $3.0 billion.
Download full bio